Plasma NfL and GFAP concentrations were significantly higher in FRDA patients than in controls (17.10 vs. 7.61 pg/mL, p < 0.001 and 99.00 vs. 59.50 pg/mL, p = 0.006, respectively). This evidence concerns the gene GFAP and Friedreich ataxia.